Rank 82 • MedTech & Devices
Organox
Creates normothermic machine perfusion devices designed to preserve donor livers at physiological temperature before transplantation.
Visit website- Signal Score
- 82.1
- Total raised
- $50M
- Stage
- Growth
- Founded
- 2008
- Headquarters
- Oxford, UK
- Region
- Europe
Their signal
Redefines organ preservation by keeping donor livers functioning outside the body, significantly increasing the pool of viable organs and improving transplant patient outcomes.
Signal Score 82.1editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.